catheter removal (13/41, 31.7%) compared to patients with catheter removal within 24 hours (5/39, 12.8%) (p < 0.01). Multivariate logistic regression analysis revealed that delayed catheter removal, the presence of intestinal obstruction, and higher white blood cell counts in the blood and in the PD effluent were independently associated with mortality in FP patients. ♦ ♦ ♦ ♦ ♦ Conclusion: These results suggest that immediate catheter removal (i.e., within 24 hours after the diagnosis of FP) is mandatory in PD patients with FP.
P eritonitis is one of the most frequent and serious complications of peritoneal dialysis (PD) and 1% -15% of all peritonitis cases are caused by fungal infections (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Although fungal peritonitis (FP) in PD patients is relatively uncommon, it is associated with significantly high morbidity and mortality. Mortality rates for FP have been reported as high as 60.5%, and several studies have demonstrated that abdominal pain and catheter in situ are associated with mortality in these patients (10) (11) (12) (13) . However, the majority of previous studies included only a small number of patients and did not evaluate the timing of catheter removal. Recently, peritonitis treatment recommendations from the International Society for Peritoneal Dialysis (ISPD) suggested that catheters should be removed from FP patients immediately after fungi are identified by either microscopy or culture (14) . However, the effect of early catheter removal on mortality has not been fully explored. In this study, therefore, we not only determine the risk factors for mortality but also investigate the effect of immediate catheter removal on mortality in PD patients with FP. Table 2 . Candida species were the most common pathogens, accounting for 74.5% of all episodes of FP, among which 55.7% were Candida albicans and 44.3% were Candida species other than Candida albicans.
PATIENTS AND METHODS
This retrospective study was conducted by reviewing the medical records of 94 FP cases among 1926 PD patients that were followed up at Yonsei University Health System from January 1992 to December 2008. The diagnosis of FP was made based on the presence of at least two of the following criteria: presence of clinical symptoms (abdominal pain, fever, cloudy dialysate), presence of more than 100 leukocytes/mm 3 dialysate with at least 50% polymorphonuclear neutrophils, and documentation of fungi in dialysate by either smear or culture (14) .
The data recorded included age at the time of FP, gender, duration of PD, cause of end-stage renal disease, residual renal function, comorbidities, presenting symptoms and signs, species of fungus causing peritonitis, presence of coexisting bacterial peritonitis, antibiotic use within the 3 months prior to FP, history of treatment with steroids, catheter removal and the time of removal, and patient outcome. The following laboratory data were obtained at the onset of peritonitis: peripheral white blood cell (WBC) count, hemoglobin, blood urea nitrogen, serum creatinine, albumin, and total cholesterol concentrations, erythrocyte sedimentation rate, C-reactive protein levels, and PD effluent leukocyte count.
Cardiovascular disease was defined as a history of coronary, cerebrovascular, or peripheral artery disease. Coronary disease was defined as history of angioplasty, coronary artery bypass graft, myocardial infarction, or angina. Cerebrovascular disease was defined as a previous transient ischemic attack, stroke, or carotid endarterectomy. Peripheral vascular disease was defined as history of claudication, ischemic limb loss and/or ulceration, or a peripheral revascularization procedure. Fungal peritonitis complicating bacterial peritonitis was defined as FP developing during treatment of bacterial peritonitis (10) . Exit-site infection was defined by the presence of purulent drainage with or without erythema of the skin at the catheter-epidermal interface (14) . Intestinal obstruction was diagnosed based on radiographic findings, such as diffusely dilated and distended air-filled bowel loop, air/fluid levels, or absence or paucity of colonic gas, in patients with nausea, vomiting, or abdominal distention requiring antiemetic agents or decompression by a nasogastric tube. No residual renal function was defined as daily urine output less than 100 mL at time of presentation. Death related to FP was defined as death of a patient with active peritonitis or sepsis secondary to peritonitis or within 4 weeks of diagnosis of FP (14) (15) (16) As soon as FP was diagnosed -15 episodes (16.0%) by Gram stain and 75 (79.8%) by culture -antifungal therapy was initiated and was maintained for 2 -6 weeks. In 4 episodes (4.3%), antifungal drugs were not given because the patients died before a diagnosis of FP could be reached. The regimen used and the route of administration were not uniform among patients with FP. Intravenous amphotericin B (0.5 -1 mg/kg per day, cumulative dose 0.5 -2 g) with or without intraperitoneal amphotericin B was used in 78 episodes (83.0%), while intravenous or oral fluconazole (200 mg per day) was used in 12 episodes (12.8%).
Removal of the PD catheter was performed in 88 episodes (93.6%) after a median duration of 2 (range 1 -9) days after the diagnosis of FP; 39 catheters (41.5%) were removed within 24 hours of the diagnosis of FP (after a median duration of 2 days after presentation with FP), whereas 42 catheters (44.7%) were removed at retard after a median duration of 3 (range 2 -9) days after the diagnosis of FP. Before the identification of fungi, 7 catheters (7.4%) were removed due to recurrent peritonitis or clinical deterioration. The PD catheter was not removed in 6 cases (6.4%); 4 patients (4.3%) died before the diagnosis of FP and 2 patients (2.1%) refused catheter removal and died after all. OUTCOME Table 3 shows the clinical outcomes of patients with FP. Twenty-seven cases of FP (28.7%) resulted in death, among which 23 deaths were related to the FP and the remaining 4 patients died of unrelated causes, including acute myocardial infarction, congestive heart failure, and bacterial pneumonia. The median duration between the diagnosis of FP and death was 21 (range 3 -83) days; 16 (range 3 -28) days for FP-related deaths and 63 (range 48 -83) days for FP-unrelated deaths. Fifty-nine episodes (62.8%) required a change to hemodialysis due to patient preference, intra-abdominal adhesions, or encapsulating peritoneal sclerosis, which developed in 4 patients (4.3%). PD was resumed in only 8 episodes (8.5%) after a median duration of 42 (range 14 -112) days after catheter removal. 
FACTORS PREDICTING MORTALITY
To determine the independent predictors for FPrelated mortality, 4 patients that died of FP-unrelated causes and 7 episodes in which the PD catheter was removed before the diagnosis of FP were excluded from the analysis. Therefore, 83 episodes of FP were analyzed, among which there were 62 survivors and 21 nonsurvivors. Cardiovascular disease, no residual renal function, delayed catheter removal (after 24 hours from the diagnosis of FP; 31.7% vs 12.8%), Candida albicans infection, fever at presentation, and complication of intestinal obstruction were more prevalent in the nonsurvivor group than in the survivor group (Table 4 ). In addition, age and WBC counts in the blood and PD effluent were significantly higher in the nonsurvivor group than in the survivor group (Table 4) .
Multivariate logistic regression analysis was performed with variables that had been revealed as significant covariates with a p value less than 0.10 on univariate analysis. The presence of abdominal pain was also included for multivariate analysis because it has been reported as a significant independent risk factor for FP-related death in many previous studies (10, 11) . Since 3 patients that died of FP-related causes and with catheter in situ were not eligible for multivariate analysis due to 100% mortality, only 80 episodes were included in the analysis. As shown in Table 5 , delayed catheter removal, the presence of intestinal obstruction, and higher WBC counts in the blood and in the PD effluent were independently associated with mortality in patients with FP. In contrast, age, the presence of cardiovascular disease, no residual renal function, Candida albicans infection, and abdominal pain or fever at presentation were not independent predictors for FP-related mortality. On the other hand, no significant interactions between these variables were observed.
DISCUSSION
Fungal peritonitis is a relatively uncommon but serious complication in PD patients. The results of this study show that the presence of intestinal obstruction and high WBC counts in the blood and in the PD effluent are closely associated with mortality in PD patients with FP. In addition, we demonstrated that early PD catheter removal improves survival in these patients, providing concrete support to the ISPD guidelines of 2005 for early catheter removal for FP.
The incidence of FP in our institute was 4.0% of 2361 peritonitis episodes over a 17-year period, with a FPrelated mortality rate of 24.5%, which is not obviously different from the results of previous studies (1-13). Since FP-related mortality is significantly higher than bacterial peritonitis-related mortality, several investigators have tried to identify the risk factors in predicting mortality in patients with FP. To date, abdominal pain with or without fever, complication by intestinal obstruction, and low serum albumin levels have been revealed as predictors for mortality in FP (10) (11) (12) (13) . In the present study, we also found that intestinal obstruction was independently associated with mortality in FP patients, which is in accordance with the results of previous studies. In contrast, this study did not find the presence of abdominal pain to be a risk factor for mortality. This disparity is likely attributable to the fact that most of our patients had abdominal pain at presentation.
All previous studies have consistently demonstrated that PD catheter in situ is an independent factor predicting mortality in FP. Wang et al. (10) reported that overall mortality rates were significantly higher in their catheter non-removal group (91%) compared to their removal group (31%), and catheter remaining in situ was confirmed by logistic regression analysis to be a significant risk factor associated with mortality. In addition, a study by Prasad et al. (11) showed that there was a significant difference, as determined by univariate analysis, in mortality between patients with and patients without catheter in situ (100.0% vs 40.9%, p = 0.01). Based on these two studies, the ISPD treatment guideline for FP has been changed from optional PD catheter removal to immediate removal after the identification of fungi (14, 17) . Even though some investigators have reported successful treatment of FP without catheter removal, the cure rates in most large studies were low (18) (19) (20) . The reason for this high treatment failure has been supposed that fungi colonize and produce a biofilm on the inner surface of the retained catheter, not only serving as a nidus for continuous fungal shedding but also rendering antifungal therapy less effective (21) (22) (23) . Therefore, most clinicians agree that catheter removal is an integral part of the treatment of FP (5-13). However, concrete evidence for the best time for catheter removal in FP has not been established. Only two studies evaluated the impact of timing of catheter removal on patient outcomes in FP. One study demonstrated that mortality was 0% if the catheter was removed within 24 hours, compared to 31% if catheter removal was delayed until after 24 hours (10) . Another recent study revealed there was a significant difference in mortality between FP patients in whom the catheter was removed within 24 hours of diagnosis versus after 24 hours (13). Even though there was a difference in mortality in the former study it did not reach statistical significance, while the predictive value of early catheter removal on mortality in the latter study was not confirmed by multivariate logistic regression analysis, probably due to a relatively small number of patients. In the present study, we show that delayed catheter removal more than 24 hours after the identification of fungi is an independent risk factor predicting mortality in FP patients. Taken together, it is suggested that immediate catheter removal is mandatory in PD patients with FP.
Another independent predictor of mortality identified in this study is high WBC count in the blood and the PD effluent. A few studies have assessed the value of WBC counts in PD effluent to predict outcomes in PD patients with peritonitis but the results are not consistent (24, 25) . We suppose that the timing of PD effluent collection may contribute to these conflicting results. In general, the WBC count in the second dialysate is higher compared to the initial turbid dialysate in PD peritonitis patients; it is also known that the WBC count in the PD effluent depends on the length of the dwell (26, 27) . Therefore, even though the results of our study suggest that the severity of the inflammatory process has an effect on the outcome of FP, further prospective study with a clear validation of the initial WBC count in the dialysate is necessary.
The number of FP episodes in the present study is higher than those of previous studies performed at a single center in Hong Kong (10) and in the USA (6) that included 70 and 55 cases respectively. Even though a very recent study by Miles et al. (9) was conducted on 162 episodes of FP in PD patients, the data were collected from 66 centers in Australia. Therefore, we consider that the present study is the largest single-center study on FP in PD patients. On the other hand, the mortality rate in our study was 28.7%, which is comparable with that in the study by Goldie et al. (6) , the largest single-center study in the USA. When compared to the data from Hong Kong (10) and the ANZDATA Registry (9), however, the incidence of death from FP in the present study was lower relative to the Hong Kong study (44.3%) but higher relative to the ANZDATA study (9.0%). We surmise that the higher mortality rates in the Hong Kong study are partly attributable to the longer median duration between the diagnosis of FP and catheter removal (7 days vs 2 days) and the lower proportion of patients transferred to permanent hemodialysis (14.5% vs 62.8%). In contrast, the incidence of death in the ANZDATA study was lower compared to our study, despite the longer median duration to catheter removal (5 days). As the authors conceded, the ANZDATA study did not collect such important information as patient compliance, individual unit management protocols, post-infection surveillance programs, and severity of comorbidities, and lacked an external audit of data accuracy, which may contribute to the difference in the rates of patient death between the ANZDATA study and our study.
In conclusion, this study shows that delayed catheter removal (more than 24 hours after the diagnosis of FP), complication by intestinal obstruction, and high WBC counts in the blood and the PD effluent are independent predictors of mortality in PD patients with FP. These findings suggest that the PD catheter should be removed immediately and certainly within 24 hours after the identification of fungi in patients with fungal peritonitis.
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